Acupuncture for Symptom Relief in Adults with Mild to Moderate Ulcerative Colitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorGuang'anmen Hospital of China Academy of Chinese Medical Sciences

About this trial

Ulcerative colitis (UC) is one of the two primary forms of inflammatory bowel disease. This condition is characterized by continuous mucosal inflammation that begins in the rectum and extends proximally throughout the colon. Common intestinal symptoms also include rectal bleeding, increased stool frequency, tenesmus, nocturnal bowel movements, and crampy abdominal pain. Acupuncture has been suggested as a potential intervention to alleviate clinical symptoms of UC. This single-center, parallel-group, two-arm, randomized, sham-controlled trial aims to evaluate the effects and safety of acupuncture for UC.

Eligibility criteria

Qualifiers

None

Disqualifiers

Diagnosis of Crohn's disease, intestinal tuberculosis, chronic intestinal infections, or intestinal malignancies.

Current treatment with corticosteroids, thiopurines, biologics, or oral small molecules.

Severe skin conditions or infections.

Presence of severe underlying medical conditions, including but not limited to cardiovascular diseases, hepatobiliary diseases, kidney diseases, hematologic disorders, autoimmune diseases, communicable diseases, severe malnutrition, or malignancies.

Trial design

Treatments tested in this trial

  • Acupuncture
  • Sham acupuncture

Treatment groups

64 Participants
are divided into 2 treatment groups

Locations

This trial has no locations